We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

CBQK:QSECommercial Bank (Q.S.C.) Analysis

Data as of 2026-03-11 - not real-time

QAR 4.74

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

The Commercial Bank trades at QAR 4.735, comfortably above its 200‑day SMA (4.51) and the 50‑day SMA (4.65) while sitting just under the 20‑day SMA (4.77), signaling a broader bullish trend but short‑term pressure. Its price‑to‑earnings ratio of 9.5 is well below the industry average of 17.1, and a price‑to‑book of 0.71 suggests the stock is priced at a discount to net assets. A dividend yield of 6.5% coupled with a 60% payout ratio makes the stock attractive for income‑focused investors, yet operating cash flow is negative (‑QAR 4.4 bn) and revenue has contracted by 10% year‑over‑year, raising questions about dividend sustainability. Volatility over the past 30 days sits at 22.5% and beta is exceptionally low (≈0.08), indicating limited market‑wide risk but heightened price swings. Analyst consensus remains positive, with eight analysts rating the stock a “buy” and a median target of QAR 5.20, implying roughly an 8% upside from current levels. Overall, the stock combines a compelling valuation gap and strong yield with emerging cash‑flow concerns that merit a balanced view.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Price holds above strong support at QAR 4.53
  • Undervalued valuation metrics (PE and PB)
  • High dividend yield offering immediate income

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Analyst target price indicating ~8% upside
  • Stable earnings margin despite revenue dip
  • Low systematic risk (beta) in a defensive sector

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Negative operating cash flow and declining revenue
  • Potential dividend sustainability concerns
  • Strong capital base and low regulatory risk in Qatar

Key Metrics & Analysis

Financial Health

Revenue Growth-10.40%
Profit Margin57.25%
P/E Ratio9.5
ROE8.26%
ROA1.23%
P/B Ratio0.7
Op. Cash FlowQAR-4417961984
Industry P/E17.1

Technical Analysis

TrendBullish
RSI52.3
SupportQAR 4.53
ResistanceQAR 4.94
MA 20QAR 4.76
MA 50QAR 4.65
MA 200QAR 4.51
MACDBearish
VolumeDecreasing
Fear & Greed Index78.16

Valuation

Target PriceQAR 5.12
Upside/Downside8.18%
GradeUndervalued
TypeValue
Dividend Yield6.49%

Risk Assessment

Beta0.09
Volatility22.48%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.